secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2026-08-05T20:05:47+00:00
Accession:  0001683168-26-005988
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paysign reports record Q2 revenue $28.3M (+48%), raises FY2026 outlook
----------------------------------------------------------------------

- Revenue $28.25M, up 48.1% YoY; GAAP net income $6.76M ($0.11 EPS) vs $1.39M ($0.02) prior year.
- Pharma revenue $14.65M (+88.9%) with 148 active programs; plasma revenue $13.04M (+21.4%) with 561 centers.
- Adjusted EBITDA $9.61M, up 113%; operating margin 24.8% (21.3% ex contingent consideration).
- Raised FY2026 revenue guidance to $114-117M and adjusted EBITDA to $35-38M.
- Balance sheet: $27.37M unrestricted cash, zero bank debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316826005988/0001683168-26-005988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316826005988/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer